The Oncologist Online -- Table of Contents Volume 13, Supplement 4, 2008

Volume 13, Supplement 4, 2008 [Index by author]

Evolving Role of CTLA-4 in Melanoma

Find articles in this issue containing these words:
[Search ALL Issues]

Receive this page by email each issue: [Sign up for eTOCs]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Introduction: Jeffrey Weber
The Oncologist 2008; 13(Supplement 4): 1; doi:10.1634/theoncologist.13-S4-1
[Full Text] [PDF]

The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation: Jedd D. Wolchok, Yvonne Saenger
The Oncologist 2008; 13(Supplement 4): 2-9; doi:10.1634/theoncologist.13-S4-2
[Abstract] [Full Text] [PDF]

Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Tremelimumab (CP-675,206): Antoni Ribas
The Oncologist 2008; 13(Supplement 4): 10-15; doi:10.1634/theoncologist.13-S4-10
[Abstract] [Full Text] [PDF]

Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Ipilimumab (MDX-010): Jeffrey Weber
The Oncologist 2008; 13(Supplement 4): 16-25; doi:10.1634/theoncologist.13-S4-16
[Abstract] [Full Text] [PDF]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Cover Illustration:

Cover

Oriental Poppy by Bernique Longley.

Laudanum, or tincture of opium, was for many decades the only "treatment" for cancer in the Old West; the Oriental Poppy has, therefore, been chosen as the journal's icon.

HOME

HELP

SUBSCRIPTIONS